Cowen Prime Advisors’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $152K | Sell |
42,301
-3,749
| -8% | -$13.5K | 0.05% | 96 |
|
|
2023
Q1 | $113K | Buy |
46,050
+4,850
| +12% | +$11.9K | 0.05% | 100 |
|
|
2022
Q4 | $64K | Sell |
41,200
-1,000
| -2% | -$1.55K | 0.03% | 119 |
|
|
2022
Q3 | $57K | Hold |
42,200
| – | – | 0.03% | 104 |
|
|
2022
Q2 | $92K | Buy |
42,200
+26,600
| +171% | +$58K | 0.05% | 96 |
|
|
2022
Q1 | $50K | Buy |
15,600
+11,850
| +316% | +$38K | 0.02% | 123 |
|
|
2021
Q4 | $16K | Buy |
3,750
+2,550
| +213% | +$10.9K | 0.01% | 145 |
|
|
2021
Q3 | $10K | Buy |
+1,200
| New | +$10K | ﹤0.01% | 149 |
|
|
2020
Q3 | – | Sell |
-42,200
| Closed | -$92K | – | 185 |
|
|
2020
Q2 | $92K | Buy |
42,200
+41,200
| +4,120% | +$89.8K | 0.05% | 96 |
|
|
2020
Q1 | $8K | Buy |
+1,000
| New | +$8K | ﹤0.01% | 158 |
|